ICON offers global, robust clinical development consulting to virtual companies, start-ups, biotechs, pharmaceutical, and medical device sponsors

Why work with us

We understand your strategic vision, working as an extension of your internal team, serving as your trusted partner. We address cross functional questions and understand the impact of gaps.

Working with us will give you a deeper understanding of development options, with respect to scientific and regulatory risks, costs and timelines, to meet overall business objectives.​ It also mean you gain access to in-depth scientific expertise across disciplines for ad hoc support.

Service offering

We offer you full lifecycle support, including clinical, regulatory and Chemistry, Manufacturing and Controls (CMC) strategies. Our innovative solutions optimize efficiency, such as adaptive design and operational adaptions in enrollment, data quality and enrichment designs.

The strategies we use to maximize Critical Path Development and minimize time-to-market include:

  • Recruitment strategies
  • Feasibility assessments
  • Use of imaging, biomarkers
     

Other services include:

  • Preparation of Product Development Plans
  • Protocol development assistance: consultation on study designs, endpoints, objectives, measurements and statistical analyses
  • Scientific and medical oversight of on-going trials
  • Patient recruitment and retention strategies
  • Liaison with KOLs and collaborative groups
  • Investigator/sponsor relationships
  • Development of Academic Advisory Boards
  • Due diligence for individual disciplines and/or across disciplines for asset assessment to support acquisitions, etc.
  • Ad-hoc consulting
  • Short to mid-term dedicated client support
  • Provision of an integrated package of clinical expertise
  • Therapeutic area and protocol training
  • Project strategy oversight
  • Assistance with scientific publishing

Out team can help you to plan and prepare development teams for interaction and negotiation with regulatory agencies. This encompasses regulatory, CMC, clinical and toxicology matters, and development of pre-meeting packages.